Charles River Laboratories International (CRL) EV to EBITDA (2009 - 2026)

Charles River Laboratories International has reported EV to EBITDA for 18 years, with the latest figure at 84.64 in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 17.09% year-over-year to 84.64 in Q2 2026; TTM through Jun 2026 was 112.57, a 93.64% increase from a year earlier, with the FY2025 full-year figure at 391.5, up 850.23% from the prior year.
• EV to EBITDA was 84.64 for Q2 2026 at Charles River Laboratories International, up from 62.69 in the prior quarter.
• The five-year high for EV to EBITDA was 108.65 in Q1 2024, with the low at 55.86 in Q4 2024.
• Average EV to EBITDA over 5 years is 61.6, with a median of 66.09 recorded in 2023.
• The largest YoY upside for EV to EBITDA was 79.35% in 2024 against a maximum downside of 162.31% in 2024.
• Over 5 years, EV to EBITDA stood at 66.6 in 2022, then soared by 34.61% to 89.65 in 2023, then tumbled by 162.31% to 55.86 in 2024, then jumped by 37.78% to 34.76 in 2025, then jumped by 343.54% to 84.64 in 2026.
• The last three EV to EBITDA figures came in at 84.64 (Q2 2026), 62.69 (Q1 2026), and 34.76 (Q4 2025), per Business Quant data.